Literature DB >> 22169801

Tumorigenesis: Testing ground for cancer stem cells.

Cathryn Delude.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 22169801     DOI： 10.1038/480S43a

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  3 in total

1.  Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells.

Authors:  Michael F Clarke; John E Dick; Peter B Dirks; Connie J Eaves; Catriona H M Jamieson; D Leanne Jones; Jane Visvader; Irving L Weissman; Geoffrey M Wahl
Journal:  Cancer Res       Date:  2006-09-21       Impact factor: 12.701

Review 2.  Cancer stem cells: controversies in multiple myeloma.

Authors:  Sarah K Brennan; William Matsui
Journal:  J Mol Med (Berl)       Date:  2009-09-17       Impact factor: 4.599

3.  A unique three-dimensional model for evaluating the impact of therapy on multiple myeloma.

Authors:  Julia Kirshner; Kyle J Thulien; Lorri D Martin; Carina Debes Marun; Tony Reiman; Andrew R Belch; Linda M Pilarski
Journal:  Blood       Date:  2008-06-05       Impact factor: 22.113
  3 in total
  14 in total

1.  Attenuation of lung cancer stem cell tumorigenesis and metastasis by cisplatin.

Authors:  Shenxu Wang; Sai Ma; Xiujuan Li; Zengfu Xue; Xiaotian Zhang; Weiwei Fan; Yongzhan Nie; Kaichun Wu; Xiaoyuan Chen; Feng Cao
Journal:  Exp Lung Res       Date:  2014-08-25       Impact factor: 2.459

Review 2.  Development of anticancer agents targeting the Hedgehog signaling.

Authors:  Xiangqian Zhang; Ye Tian; Yanling Yang; Jijun Hao
Journal:  Cell Mol Life Sci       Date:  2017-03-17       Impact factor: 9.261

3.  Lgr5 is a potential prognostic marker in patients with cervical carcinoma.

Authors:  Bo Sun; Xiufeng Ye; Yuan Li; Weiyuan Zhang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

4.  MiRNA-34a overexpression inhibits multiple myeloma cancer stem cell growth in mice by suppressing TGIF2.

Authors:  Songyan Wu; Xiangfeng He; Miao Li; Fangfang Shi; Di Wu; Meng Pan; Mei Guo; Rong Zhang; Shouhua Luo; Ning Gu; Jun Dou
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

5.  Malignant transformation of bone marrow stromal cells induced by the brain glioma niche in rats.

Authors:  Qiuping He; Xifeng Zou; Deyi Duan; Yujun Liu; Qunyuan Xu
Journal:  Mol Cell Biochem       Date:  2015-11-21       Impact factor: 3.396

6.  MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma.

Authors:  Juan Du; Shuyan Liu; Jie He; Xi Liu; Ying Qu; Wenqing Yan; Jianling Fan; Rong Li; Hao Xi; Weijun Fu; Chunyang Zhang; Jing Yang; Jian Hou
Journal:  Oncotarget       Date:  2015-06-20

Review 7.  A review of stem cell translation and potential confounds by cancer stem cells.

Authors:  Bernadette Bibber; Garima Sinha; Aline R M Lobba; Steven J Greco; Pranela Rameshwar
Journal:  Stem Cells Int       Date:  2013-12-10       Impact factor: 5.443

8.  Properties and feasibility of using cancer stem cells in clinical cancer treatment.

Authors:  Xiao-Mei Gao; Rui Zhang; Qiong-Zhu Dong; Lun-Xiu Qin
Journal:  Cancer Biol Med       Date:  2016-12       Impact factor: 4.248

9.  Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transition.

Authors:  Ying Bao; Yongliang Lu; Xiang Wang; Wenming Feng; Xinrong Sun; Huihui Guo; Chengwu Tang; Xiaojing Zhang; Qilin Shi; Hongbin Yu
Journal:  Cancer Cell Int       Date:  2015-11-17       Impact factor: 5.722

10.  CD133 expression may be useful as a prognostic indicator in colorectal cancer, a tool for optimizing therapy and supportive evidence for the cancer stem cell hypothesis: a meta-analysis.

Authors:  Yang Zhao; Jing Peng; Enlong Zhang; Ning Jiang; Jiang Li; Qi Zhang; Xuening Zhang; Yuanjie Niu
Journal:  Oncotarget       Date:  2016-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.